High-dose Vitamin D Supplementation on Type 1 Diabetes Mellitus Patients: Is there an Improvement in Glycemic Control?
- 1 January 2022
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 18 (1), 1
- https://doi.org/10.2174/1573399817666210106102643
Abstract
Background: Some authors evaluated the effect of VD on hyperglycemia in T1DM, but the results remain controversial. This study aims to analyze the effects of high-dose VD supplementation on T1DM patients’ glycemic levels, maintaining stable doses of insulin. Methods: Prospective, 12-week clinical trial including 67 T1DM patients, who were supplemented with high doses of cholecalciferol according to participants' VD value. Patients with VD levels below 30 ng/mL received 10,000 IU/day; those with levels between 30-60 ng/mL received 4,000 IU/day. Patients who had not achieved 25(OH)D levels > 30 ng/ml or presented insulin dose variation during the study were not analyzed. Results: Only 46 out of 67 patients accomplished the criteria at the end of the study. There was no general improvement in the glycemic control evaluated by HbA1c (9.4 ± 2.4 vs 9.4 ± 2.6, p=NS) after VD supplementation. However, a posthoc analysis, based on HbA1c variation, identified patients who had HbA1c reduced at least 0.6% (group 1, N = 13 (28%)). In addition, a correlation between 25(OH)D levels with HbA1c and total insulin dose at the end of the study was observed (r = -0.3, p<0.05; r=-0.4, p<0.05, respectively) and a regression model demonstrated that 25(OH)D was independent of BMI, duration of T1DM and final total insulin dose, being capable of determining 9.2% of HbA1c final levels (Unstandardized B coefficient = −0.033 (CI 95%: −0.064 to −0.002), r² = 0.1, p <0.05). Conclusion: Our data suggests that VD is not widely recommended for glycemic control. Nevertheless, specific patients might benefit from this approach.Keywords
This publication has 40 references indexed in Scilit:
- Dysglycaemia as a cause of cardiovascular outcomesNature Reviews Endocrinology, 2015
- Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!Diabetes Care, 2015
- Common Variants in CYP2R1 and GC Genes Predict Vitamin D Concentrations in Healthy Danish Children and AdultsPLOS ONE, 2014
- Vitamin D and DiabetesEndocrinology and Metabolism Clinics of North America, 2013
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: OverviewDiabetes Care, 2013
- Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice GuidelineJournal of Clinical Endocrinology & Metabolism, 2011
- Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiencyAnnals of Saudi Medicine, 2010
- No Protective Effect of Calcitriol on β-Cell Function in Recent-Onset Type 1 DiabetesDiabetes Care, 2010
- Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjectsActa Endocrinologica, 2008
- The effects of calcitriol and nicotinamide on residual pancreatic β‐cell function in patients with recent‐onset Type 1 diabetes (IMDIAB XI)Diabetic Medicine, 2006